SITC 30th Anniversary Annual Meeting (2015): Immunogenomics and OncogeneticsNovember 6-8, 2015 Gaylord National Hotel & Convention Center National Harbor, MDSession Co-Chairs Francesco M. Marincola, MD – Sidra Medical and Research Center Kai Wucherpfennig, MD, PhD – Harvard Medical School Program SummaryGenetic approaches are revealing key determinants of productive immune responses in cancers. Recent work on human cancers has shown that responses to checkpoint blockade depend on the mutational load of tumors, with non-synonymous mutations creating neo-epitopes for T cell recognition. Expression signatures of human cancers can also reveal how cancers shape the composition of the immune infiltrate. The session at the SITC 30th Anniversary Annual Meeting on Friday, November 6, 2015 in National Harbor, MD covered cutting-edge genetic approaches in the investigation of tumor immunity and the creation of novel relevant mouse models. SITC 30th Anniversary Annual Meeting Organizers Sandra Demaria, MD – Weill Cornell Medical College Madhav Dhodapkar, MD – Yale University Pamela S. Ohashi, PhD – Princess Margaret Cancer Centre Jennifer A. Wargo, MD – University of Texas MD Anderson Cancer Center Andrew D. Weinberg, PhD – Earle A. Chiles Research InstituteAbout the SITC 30th Anniversary Annual MeetingSITC's 30th Anniversary Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving the outcome for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy research. The meeting consisted of cutting-edge research presentations by experts in the field, oral and poster abstract presentations and ample opportunity for both structured and informal discussions including important networking opportunities. In addition, the meeting included updates on major national and international initiatives coming from academia, government and industry, as well as ongoing SITC projects. Target AudienceThe target audience for this program included basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers that wished to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment. #AnnualMeeting #2015 #BreastCancers #GastrointestinalCancers #Melanoma #PresentationSlides #SITC #Clinician #Industry #Oncologist #Researcher
Meeting: SITC 30th Anniversary Annual Meeting; Session: Adoptive Immunotherapy; Presentation: Understanding the CD8T Cell Response to Melanoma Using Transnuclear Mouse Models; Presenter: Stephanie Dougan, PhD – Dana-Farber Cancer Institute; Date: November 6, 201500:13:17
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us